1560nok
-0,6 %
Date:2025-06-06Time:09:45:00Latest report:Q1-2025List:Oslo BorsTicker:AZT
Market Cap:797 mnokEnterprise Value:636 mnokNet Sales:99,5 mnokEarnings:1,29 mnokEmployees:0ISIN:NO0010014632

Ratios

10-year key figure history for ArcticZymes turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for ArcticZymes with index and moving average MA50 and MA200.

Stockprice:15,60
MA50:16,47
MA200:16,20
Price/MA200:-3,7 %
RSI (14):45,0
Price/MA50:-5,3 %

Description

ArcticZymes Technologies is a biotechnology company. The company specializes in the research and development of pharmaceuticals for the treatment of immune diseases. The main focus is on the development of glucans, the development of immune-stimulating agents, and the analysis of enzymes. The vision is to test and develop the medicine and then pass these on in use for RNA and DNA processes. ArcticZymes Technologies previously went by the name Biotec Pharmacon and is headquartered in Tromsö.

Biotechnology